All articles by Staff Writer
Staff Writer
Cormica expands US presence with acquisition of Focus Laboratories
Cormica continues expansion with acquisition of microbiological testing firm, Focus Laboratories, following strategic German acquisition
Certest and TÜV Rheinland, a story of success
After being working on it for a long time, they can finally announce it.
Medlab Middle East looks to the future of laboratories as the market is estimated to reach USD473.84 million by 2029
The medical laboratory market in the Middle East and Africa (MEA) is on track for remarkable growth, with recent research projecting it to reach USD473.84 million by 2029 at a robust Compound Annual Growth Rate (CAGR) of 12.6%. Against this promising backdrop, Medlab Middle East, taking place from 3-6 February, will bring together medical laboratory professionals and industry leaders to explore the future of laboratories and their transformative impact on healthcare in the region and beyond.
BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®
Study of Vendaje® versus standard of care aims to show superior wound treatment, supporting market expansion
Co-Dx and CoSara inaugurate oligo synthesis facility in Ranoli, India
Co-Dx and our Indian joint venture, CoSara Diagnostics Pvt. Ltd, inaugurated the oligonucleotide synthesis facility in Ranoli, India on December 11, 2024. The new facility is designed to support the “Make in India” initiative by manufacturing our patented Co-Primers® chemistry, which has been used in the Co-Dx and CoSara lab-based PCR tests for years, and will also power the test cups for the upcoming Co-Dx PCR at-home and POC testing platform.*
Cormica expands European operations with acquisition of Zwisler Laboratorium GmbH
Cormica, a global leader in life sciences testing and consulting, has completed the acquisition of Zwisler Laboratorium, a premier provider of laboratory services headquartered in Reichenau, Germany.
QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. regulatory clearance of the first in a series of QIAstat-Dx Gastrointestinal Panel tests for clinical use.
QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more than two-fold increase in the number of targets that can be simultaneously analyzed from a single biological sample.
QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of two new tools for designing and ordering custom solutions that can be used to support microbial analysis of bacterial, fungal and viral targets.
BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental Allografts
Company continues to advance its placental-derived product portfolio with the first patent granted in the fenestrated wound care market